Global Acute Myeloid Leukemia Biomarker Detection Supply, Demand and Key Producers, 2023-2029
The global Acute Myeloid Leukemia Biomarker Detection market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Acute myeloid leukemia is a malignant neoplastic disease that usually results from the deterioration of stem cells in the bone marrow. Biomarker detection is a method that can detect specific molecular or genetic variations of leukemia cells, which can be used to diagnose AML, evaluate patient prognosis, and guide the selection of treatment options.
This report studies the global Acute Myeloid Leukemia Biomarker Detection production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Acute Myeloid Leukemia Biomarker Detection, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Acute Myeloid Leukemia Biomarker Detection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Acute Myeloid Leukemia Biomarker Detection total production and demand, 2018-2029, (K Units)
Global Acute Myeloid Leukemia Biomarker Detection total production value, 2018-2029, (USD Million)
Global Acute Myeloid Leukemia Biomarker Detection production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Acute Myeloid Leukemia Biomarker Detection consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Acute Myeloid Leukemia Biomarker Detection domestic production, consumption, key domestic manufacturers and share
Global Acute Myeloid Leukemia Biomarker Detection production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Acute Myeloid Leukemia Biomarker Detection production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Acute Myeloid Leukemia Biomarker Detection production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Acute Myeloid Leukemia Biomarker Detection market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Bio-Rad Laboratories, Inc., Genmark Saghlk Orinleri, Laboratory Corporation of America Holdings, Danaher, Medaysis Company, NeoGenomics Laboratories, QIAGEN N.V. and Thermo Fisher Scientific, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Acute Myeloid Leukemia Biomarker Detection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Acute Myeloid Leukemia Biomarker Detection Market, By Region:
1. How big is the global Acute Myeloid Leukemia Biomarker Detection market?
2. What is the demand of the global Acute Myeloid Leukemia Biomarker Detection market?
3. What is the year over year growth of the global Acute Myeloid Leukemia Biomarker Detection market?
4. What is the production and production value of the global Acute Myeloid Leukemia Biomarker Detection market?
5. Who are the key producers in the global Acute Myeloid Leukemia Biomarker Detection market?
6. What are the growth factors driving the market demand?
Acute myeloid leukemia is a malignant neoplastic disease that usually results from the deterioration of stem cells in the bone marrow. Biomarker detection is a method that can detect specific molecular or genetic variations of leukemia cells, which can be used to diagnose AML, evaluate patient prognosis, and guide the selection of treatment options.
This report studies the global Acute Myeloid Leukemia Biomarker Detection production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Acute Myeloid Leukemia Biomarker Detection, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Acute Myeloid Leukemia Biomarker Detection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Acute Myeloid Leukemia Biomarker Detection total production and demand, 2018-2029, (K Units)
Global Acute Myeloid Leukemia Biomarker Detection total production value, 2018-2029, (USD Million)
Global Acute Myeloid Leukemia Biomarker Detection production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Acute Myeloid Leukemia Biomarker Detection consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Acute Myeloid Leukemia Biomarker Detection domestic production, consumption, key domestic manufacturers and share
Global Acute Myeloid Leukemia Biomarker Detection production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Acute Myeloid Leukemia Biomarker Detection production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Acute Myeloid Leukemia Biomarker Detection production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Acute Myeloid Leukemia Biomarker Detection market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Bio-Rad Laboratories, Inc., Genmark Saghlk Orinleri, Laboratory Corporation of America Holdings, Danaher, Medaysis Company, NeoGenomics Laboratories, QIAGEN N.V. and Thermo Fisher Scientific, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Acute Myeloid Leukemia Biomarker Detection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Acute Myeloid Leukemia Biomarker Detection Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Next Generation Sequencing Technology
- PCR Detection Technology
- Hospital
- Research Institutions
- Other
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- Genmark Saghlk Orinleri
- Laboratory Corporation of America Holdings
- Danaher
- Medaysis Company
- NeoGenomics Laboratories
- QIAGEN N.V.
- Thermo Fisher Scientific, Inc.
- GeneTex
1. How big is the global Acute Myeloid Leukemia Biomarker Detection market?
2. What is the demand of the global Acute Myeloid Leukemia Biomarker Detection market?
3. What is the year over year growth of the global Acute Myeloid Leukemia Biomarker Detection market?
4. What is the production and production value of the global Acute Myeloid Leukemia Biomarker Detection market?
5. Who are the key producers in the global Acute Myeloid Leukemia Biomarker Detection market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Acute Myeloid Leukemia Biomarker Detection Introduction
1.2 World Acute Myeloid Leukemia Biomarker Detection Supply & Forecast
1.2.1 World Acute Myeloid Leukemia Biomarker Detection Production Value (2018 & 2022 & 2029)
1.2.2 World Acute Myeloid Leukemia Biomarker Detection Production (2018-2029)
1.2.3 World Acute Myeloid Leukemia Biomarker Detection Pricing Trends (2018-2029)
1.3 World Acute Myeloid Leukemia Biomarker Detection Production by Region (Based on Production Site)
1.3.1 World Acute Myeloid Leukemia Biomarker Detection Production Value by Region (2018-2029)
1.3.2 World Acute Myeloid Leukemia Biomarker Detection Production by Region (2018-2029)
1.3.3 World Acute Myeloid Leukemia Biomarker Detection Average Price by Region (2018-2029)
1.3.4 North America Acute Myeloid Leukemia Biomarker Detection Production (2018-2029)
1.3.5 Europe Acute Myeloid Leukemia Biomarker Detection Production (2018-2029)
1.3.6 China Acute Myeloid Leukemia Biomarker Detection Production (2018-2029)
1.3.7 Japan Acute Myeloid Leukemia Biomarker Detection Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Acute Myeloid Leukemia Biomarker Detection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Acute Myeloid Leukemia Biomarker Detection Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Acute Myeloid Leukemia Biomarker Detection Demand (2018-2029)
2.2 World Acute Myeloid Leukemia Biomarker Detection Consumption by Region
2.2.1 World Acute Myeloid Leukemia Biomarker Detection Consumption by Region (2018-2023)
2.2.2 World Acute Myeloid Leukemia Biomarker Detection Consumption Forecast by Region (2024-2029)
2.3 United States Acute Myeloid Leukemia Biomarker Detection Consumption (2018-2029)
2.4 China Acute Myeloid Leukemia Biomarker Detection Consumption (2018-2029)
2.5 Europe Acute Myeloid Leukemia Biomarker Detection Consumption (2018-2029)
2.6 Japan Acute Myeloid Leukemia Biomarker Detection Consumption (2018-2029)
2.7 South Korea Acute Myeloid Leukemia Biomarker Detection Consumption (2018-2029)
2.8 ASEAN Acute Myeloid Leukemia Biomarker Detection Consumption (2018-2029)
2.9 India Acute Myeloid Leukemia Biomarker Detection Consumption (2018-2029)
3 WORLD ACUTE MYELOID LEUKEMIA BIOMARKER DETECTION MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Acute Myeloid Leukemia Biomarker Detection Production Value by Manufacturer (2018-2023)
3.2 World Acute Myeloid Leukemia Biomarker Detection Production by Manufacturer (2018-2023)
3.3 World Acute Myeloid Leukemia Biomarker Detection Average Price by Manufacturer (2018-2023)
3.4 Acute Myeloid Leukemia Biomarker Detection Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Acute Myeloid Leukemia Biomarker Detection Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Acute Myeloid Leukemia Biomarker Detection in 2022
3.5.3 Global Concentration Ratios (CR8) for Acute Myeloid Leukemia Biomarker Detection in 2022
3.6 Acute Myeloid Leukemia Biomarker Detection Market: Overall Company Footprint Analysis
3.6.1 Acute Myeloid Leukemia Biomarker Detection Market: Region Footprint
3.6.2 Acute Myeloid Leukemia Biomarker Detection Market: Company Product Type Footprint
3.6.3 Acute Myeloid Leukemia Biomarker Detection Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Acute Myeloid Leukemia Biomarker Detection Production Value Comparison
4.1.1 United States VS China: Acute Myeloid Leukemia Biomarker Detection Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Acute Myeloid Leukemia Biomarker Detection Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Acute Myeloid Leukemia Biomarker Detection Production Comparison
4.2.1 United States VS China: Acute Myeloid Leukemia Biomarker Detection Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Acute Myeloid Leukemia Biomarker Detection Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Acute Myeloid Leukemia Biomarker Detection Consumption Comparison
4.3.1 United States VS China: Acute Myeloid Leukemia Biomarker Detection Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Acute Myeloid Leukemia Biomarker Detection Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Acute Myeloid Leukemia Biomarker Detection Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Acute Myeloid Leukemia Biomarker Detection Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production Value (2018-2023)
4.4.3 United States Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production (2018-2023)
4.5 China Based Acute Myeloid Leukemia Biomarker Detection Manufacturers and Market Share
4.5.1 China Based Acute Myeloid Leukemia Biomarker Detection Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production Value (2018-2023)
4.5.3 China Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production (2018-2023)
4.6 Rest of World Based Acute Myeloid Leukemia Biomarker Detection Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Acute Myeloid Leukemia Biomarker Detection Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Acute Myeloid Leukemia Biomarker Detection Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Next Generation Sequencing Technology
5.2.2 PCR Detection Technology
5.3 Market Segment by Type
5.3.1 World Acute Myeloid Leukemia Biomarker Detection Production by Type (2018-2029)
5.3.2 World Acute Myeloid Leukemia Biomarker Detection Production Value by Type (2018-2029)
5.3.3 World Acute Myeloid Leukemia Biomarker Detection Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Acute Myeloid Leukemia Biomarker Detection Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Research Institutions
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Acute Myeloid Leukemia Biomarker Detection Production by Application (2018-2029)
6.3.2 World Acute Myeloid Leukemia Biomarker Detection Production Value by Application (2018-2029)
6.3.3 World Acute Myeloid Leukemia Biomarker Detection Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Details
7.1.2 Abbott Laboratories Major Business
7.1.3 Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Product and Services
7.1.4 Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Abbott Laboratories Recent Developments/Updates
7.1.6 Abbott Laboratories Competitive Strengths & Weaknesses
7.2 Bio-Rad Laboratories, Inc.
7.2.1 Bio-Rad Laboratories, Inc. Details
7.2.2 Bio-Rad Laboratories, Inc. Major Business
7.2.3 Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Product and Services
7.2.4 Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Bio-Rad Laboratories, Inc. Recent Developments/Updates
7.2.6 Bio-Rad Laboratories, Inc. Competitive Strengths & Weaknesses
7.3 Genmark Saghlk Orinleri
7.3.1 Genmark Saghlk Orinleri Details
7.3.2 Genmark Saghlk Orinleri Major Business
7.3.3 Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Product and Services
7.3.4 Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Genmark Saghlk Orinleri Recent Developments/Updates
7.3.6 Genmark Saghlk Orinleri Competitive Strengths & Weaknesses
7.4 Laboratory Corporation of America Holdings
7.4.1 Laboratory Corporation of America Holdings Details
7.4.2 Laboratory Corporation of America Holdings Major Business
7.4.3 Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Product and Services
7.4.4 Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Laboratory Corporation of America Holdings Recent Developments/Updates
7.4.6 Laboratory Corporation of America Holdings Competitive Strengths & Weaknesses
7.5 Danaher
7.5.1 Danaher Details
7.5.2 Danaher Major Business
7.5.3 Danaher Acute Myeloid Leukemia Biomarker Detection Product and Services
7.5.4 Danaher Acute Myeloid Leukemia Biomarker Detection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Danaher Recent Developments/Updates
7.5.6 Danaher Competitive Strengths & Weaknesses
7.6 Medaysis Company
7.6.1 Medaysis Company Details
7.6.2 Medaysis Company Major Business
7.6.3 Medaysis Company Acute Myeloid Leukemia Biomarker Detection Product and Services
7.6.4 Medaysis Company Acute Myeloid Leukemia Biomarker Detection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Medaysis Company Recent Developments/Updates
7.6.6 Medaysis Company Competitive Strengths & Weaknesses
7.7 NeoGenomics Laboratories
7.7.1 NeoGenomics Laboratories Details
7.7.2 NeoGenomics Laboratories Major Business
7.7.3 NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Product and Services
7.7.4 NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 NeoGenomics Laboratories Recent Developments/Updates
7.7.6 NeoGenomics Laboratories Competitive Strengths & Weaknesses
7.8 QIAGEN N.V.
7.8.1 QIAGEN N.V. Details
7.8.2 QIAGEN N.V. Major Business
7.8.3 QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Product and Services
7.8.4 QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 QIAGEN N.V. Recent Developments/Updates
7.8.6 QIAGEN N.V. Competitive Strengths & Weaknesses
7.9 Thermo Fisher Scientific, Inc.
7.9.1 Thermo Fisher Scientific, Inc. Details
7.9.2 Thermo Fisher Scientific, Inc. Major Business
7.9.3 Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Product and Services
7.9.4 Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Thermo Fisher Scientific, Inc. Recent Developments/Updates
7.9.6 Thermo Fisher Scientific, Inc. Competitive Strengths & Weaknesses
7.10 GeneTex
7.10.1 GeneTex Details
7.10.2 GeneTex Major Business
7.10.3 GeneTex Acute Myeloid Leukemia Biomarker Detection Product and Services
7.10.4 GeneTex Acute Myeloid Leukemia Biomarker Detection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 GeneTex Recent Developments/Updates
7.10.6 GeneTex Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Acute Myeloid Leukemia Biomarker Detection Industry Chain
8.2 Acute Myeloid Leukemia Biomarker Detection Upstream Analysis
8.2.1 Acute Myeloid Leukemia Biomarker Detection Core Raw Materials
8.2.2 Main Manufacturers of Acute Myeloid Leukemia Biomarker Detection Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Acute Myeloid Leukemia Biomarker Detection Production Mode
8.6 Acute Myeloid Leukemia Biomarker Detection Procurement Model
8.7 Acute Myeloid Leukemia Biomarker Detection Industry Sales Model and Sales Channels
8.7.1 Acute Myeloid Leukemia Biomarker Detection Sales Model
8.7.2 Acute Myeloid Leukemia Biomarker Detection Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Acute Myeloid Leukemia Biomarker Detection Introduction
1.2 World Acute Myeloid Leukemia Biomarker Detection Supply & Forecast
1.2.1 World Acute Myeloid Leukemia Biomarker Detection Production Value (2018 & 2022 & 2029)
1.2.2 World Acute Myeloid Leukemia Biomarker Detection Production (2018-2029)
1.2.3 World Acute Myeloid Leukemia Biomarker Detection Pricing Trends (2018-2029)
1.3 World Acute Myeloid Leukemia Biomarker Detection Production by Region (Based on Production Site)
1.3.1 World Acute Myeloid Leukemia Biomarker Detection Production Value by Region (2018-2029)
1.3.2 World Acute Myeloid Leukemia Biomarker Detection Production by Region (2018-2029)
1.3.3 World Acute Myeloid Leukemia Biomarker Detection Average Price by Region (2018-2029)
1.3.4 North America Acute Myeloid Leukemia Biomarker Detection Production (2018-2029)
1.3.5 Europe Acute Myeloid Leukemia Biomarker Detection Production (2018-2029)
1.3.6 China Acute Myeloid Leukemia Biomarker Detection Production (2018-2029)
1.3.7 Japan Acute Myeloid Leukemia Biomarker Detection Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Acute Myeloid Leukemia Biomarker Detection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Acute Myeloid Leukemia Biomarker Detection Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Acute Myeloid Leukemia Biomarker Detection Demand (2018-2029)
2.2 World Acute Myeloid Leukemia Biomarker Detection Consumption by Region
2.2.1 World Acute Myeloid Leukemia Biomarker Detection Consumption by Region (2018-2023)
2.2.2 World Acute Myeloid Leukemia Biomarker Detection Consumption Forecast by Region (2024-2029)
2.3 United States Acute Myeloid Leukemia Biomarker Detection Consumption (2018-2029)
2.4 China Acute Myeloid Leukemia Biomarker Detection Consumption (2018-2029)
2.5 Europe Acute Myeloid Leukemia Biomarker Detection Consumption (2018-2029)
2.6 Japan Acute Myeloid Leukemia Biomarker Detection Consumption (2018-2029)
2.7 South Korea Acute Myeloid Leukemia Biomarker Detection Consumption (2018-2029)
2.8 ASEAN Acute Myeloid Leukemia Biomarker Detection Consumption (2018-2029)
2.9 India Acute Myeloid Leukemia Biomarker Detection Consumption (2018-2029)
3 WORLD ACUTE MYELOID LEUKEMIA BIOMARKER DETECTION MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Acute Myeloid Leukemia Biomarker Detection Production Value by Manufacturer (2018-2023)
3.2 World Acute Myeloid Leukemia Biomarker Detection Production by Manufacturer (2018-2023)
3.3 World Acute Myeloid Leukemia Biomarker Detection Average Price by Manufacturer (2018-2023)
3.4 Acute Myeloid Leukemia Biomarker Detection Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Acute Myeloid Leukemia Biomarker Detection Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Acute Myeloid Leukemia Biomarker Detection in 2022
3.5.3 Global Concentration Ratios (CR8) for Acute Myeloid Leukemia Biomarker Detection in 2022
3.6 Acute Myeloid Leukemia Biomarker Detection Market: Overall Company Footprint Analysis
3.6.1 Acute Myeloid Leukemia Biomarker Detection Market: Region Footprint
3.6.2 Acute Myeloid Leukemia Biomarker Detection Market: Company Product Type Footprint
3.6.3 Acute Myeloid Leukemia Biomarker Detection Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Acute Myeloid Leukemia Biomarker Detection Production Value Comparison
4.1.1 United States VS China: Acute Myeloid Leukemia Biomarker Detection Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Acute Myeloid Leukemia Biomarker Detection Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Acute Myeloid Leukemia Biomarker Detection Production Comparison
4.2.1 United States VS China: Acute Myeloid Leukemia Biomarker Detection Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Acute Myeloid Leukemia Biomarker Detection Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Acute Myeloid Leukemia Biomarker Detection Consumption Comparison
4.3.1 United States VS China: Acute Myeloid Leukemia Biomarker Detection Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Acute Myeloid Leukemia Biomarker Detection Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Acute Myeloid Leukemia Biomarker Detection Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Acute Myeloid Leukemia Biomarker Detection Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production Value (2018-2023)
4.4.3 United States Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production (2018-2023)
4.5 China Based Acute Myeloid Leukemia Biomarker Detection Manufacturers and Market Share
4.5.1 China Based Acute Myeloid Leukemia Biomarker Detection Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production Value (2018-2023)
4.5.3 China Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production (2018-2023)
4.6 Rest of World Based Acute Myeloid Leukemia Biomarker Detection Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Acute Myeloid Leukemia Biomarker Detection Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Acute Myeloid Leukemia Biomarker Detection Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Next Generation Sequencing Technology
5.2.2 PCR Detection Technology
5.3 Market Segment by Type
5.3.1 World Acute Myeloid Leukemia Biomarker Detection Production by Type (2018-2029)
5.3.2 World Acute Myeloid Leukemia Biomarker Detection Production Value by Type (2018-2029)
5.3.3 World Acute Myeloid Leukemia Biomarker Detection Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Acute Myeloid Leukemia Biomarker Detection Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Research Institutions
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Acute Myeloid Leukemia Biomarker Detection Production by Application (2018-2029)
6.3.2 World Acute Myeloid Leukemia Biomarker Detection Production Value by Application (2018-2029)
6.3.3 World Acute Myeloid Leukemia Biomarker Detection Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Details
7.1.2 Abbott Laboratories Major Business
7.1.3 Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Product and Services
7.1.4 Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Abbott Laboratories Recent Developments/Updates
7.1.6 Abbott Laboratories Competitive Strengths & Weaknesses
7.2 Bio-Rad Laboratories, Inc.
7.2.1 Bio-Rad Laboratories, Inc. Details
7.2.2 Bio-Rad Laboratories, Inc. Major Business
7.2.3 Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Product and Services
7.2.4 Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Bio-Rad Laboratories, Inc. Recent Developments/Updates
7.2.6 Bio-Rad Laboratories, Inc. Competitive Strengths & Weaknesses
7.3 Genmark Saghlk Orinleri
7.3.1 Genmark Saghlk Orinleri Details
7.3.2 Genmark Saghlk Orinleri Major Business
7.3.3 Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Product and Services
7.3.4 Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Genmark Saghlk Orinleri Recent Developments/Updates
7.3.6 Genmark Saghlk Orinleri Competitive Strengths & Weaknesses
7.4 Laboratory Corporation of America Holdings
7.4.1 Laboratory Corporation of America Holdings Details
7.4.2 Laboratory Corporation of America Holdings Major Business
7.4.3 Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Product and Services
7.4.4 Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Laboratory Corporation of America Holdings Recent Developments/Updates
7.4.6 Laboratory Corporation of America Holdings Competitive Strengths & Weaknesses
7.5 Danaher
7.5.1 Danaher Details
7.5.2 Danaher Major Business
7.5.3 Danaher Acute Myeloid Leukemia Biomarker Detection Product and Services
7.5.4 Danaher Acute Myeloid Leukemia Biomarker Detection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Danaher Recent Developments/Updates
7.5.6 Danaher Competitive Strengths & Weaknesses
7.6 Medaysis Company
7.6.1 Medaysis Company Details
7.6.2 Medaysis Company Major Business
7.6.3 Medaysis Company Acute Myeloid Leukemia Biomarker Detection Product and Services
7.6.4 Medaysis Company Acute Myeloid Leukemia Biomarker Detection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Medaysis Company Recent Developments/Updates
7.6.6 Medaysis Company Competitive Strengths & Weaknesses
7.7 NeoGenomics Laboratories
7.7.1 NeoGenomics Laboratories Details
7.7.2 NeoGenomics Laboratories Major Business
7.7.3 NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Product and Services
7.7.4 NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 NeoGenomics Laboratories Recent Developments/Updates
7.7.6 NeoGenomics Laboratories Competitive Strengths & Weaknesses
7.8 QIAGEN N.V.
7.8.1 QIAGEN N.V. Details
7.8.2 QIAGEN N.V. Major Business
7.8.3 QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Product and Services
7.8.4 QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 QIAGEN N.V. Recent Developments/Updates
7.8.6 QIAGEN N.V. Competitive Strengths & Weaknesses
7.9 Thermo Fisher Scientific, Inc.
7.9.1 Thermo Fisher Scientific, Inc. Details
7.9.2 Thermo Fisher Scientific, Inc. Major Business
7.9.3 Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Product and Services
7.9.4 Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Thermo Fisher Scientific, Inc. Recent Developments/Updates
7.9.6 Thermo Fisher Scientific, Inc. Competitive Strengths & Weaknesses
7.10 GeneTex
7.10.1 GeneTex Details
7.10.2 GeneTex Major Business
7.10.3 GeneTex Acute Myeloid Leukemia Biomarker Detection Product and Services
7.10.4 GeneTex Acute Myeloid Leukemia Biomarker Detection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 GeneTex Recent Developments/Updates
7.10.6 GeneTex Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Acute Myeloid Leukemia Biomarker Detection Industry Chain
8.2 Acute Myeloid Leukemia Biomarker Detection Upstream Analysis
8.2.1 Acute Myeloid Leukemia Biomarker Detection Core Raw Materials
8.2.2 Main Manufacturers of Acute Myeloid Leukemia Biomarker Detection Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Acute Myeloid Leukemia Biomarker Detection Production Mode
8.6 Acute Myeloid Leukemia Biomarker Detection Procurement Model
8.7 Acute Myeloid Leukemia Biomarker Detection Industry Sales Model and Sales Channels
8.7.1 Acute Myeloid Leukemia Biomarker Detection Sales Model
8.7.2 Acute Myeloid Leukemia Biomarker Detection Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Acute Myeloid Leukemia Biomarker Detection Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Acute Myeloid Leukemia Biomarker Detection Production Value by Region (2018-2023) & (USD Million)
Table 3. World Acute Myeloid Leukemia Biomarker Detection Production Value by Region (2024-2029) & (USD Million)
Table 4. World Acute Myeloid Leukemia Biomarker Detection Production Value Market Share by Region (2018-2023)
Table 5. World Acute Myeloid Leukemia Biomarker Detection Production Value Market Share by Region (2024-2029)
Table 6. World Acute Myeloid Leukemia Biomarker Detection Production by Region (2018-2023) & (K Units)
Table 7. World Acute Myeloid Leukemia Biomarker Detection Production by Region (2024-2029) & (K Units)
Table 8. World Acute Myeloid Leukemia Biomarker Detection Production Market Share by Region (2018-2023)
Table 9. World Acute Myeloid Leukemia Biomarker Detection Production Market Share by Region (2024-2029)
Table 10. World Acute Myeloid Leukemia Biomarker Detection Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Acute Myeloid Leukemia Biomarker Detection Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Acute Myeloid Leukemia Biomarker Detection Major Market Trends
Table 13. World Acute Myeloid Leukemia Biomarker Detection Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Acute Myeloid Leukemia Biomarker Detection Consumption by Region (2018-2023) & (K Units)
Table 15. World Acute Myeloid Leukemia Biomarker Detection Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Acute Myeloid Leukemia Biomarker Detection Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Acute Myeloid Leukemia Biomarker Detection Producers in 2022
Table 18. World Acute Myeloid Leukemia Biomarker Detection Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Acute Myeloid Leukemia Biomarker Detection Producers in 2022
Table 20. World Acute Myeloid Leukemia Biomarker Detection Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Acute Myeloid Leukemia Biomarker Detection Company Evaluation Quadrant
Table 22. World Acute Myeloid Leukemia Biomarker Detection Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Acute Myeloid Leukemia Biomarker Detection Production Site of Key Manufacturer
Table 24. Acute Myeloid Leukemia Biomarker Detection Market: Company Product Type Footprint
Table 25. Acute Myeloid Leukemia Biomarker Detection Market: Company Product Application Footprint
Table 26. Acute Myeloid Leukemia Biomarker Detection Competitive Factors
Table 27. Acute Myeloid Leukemia Biomarker Detection New Entrant and Capacity Expansion Plans
Table 28. Acute Myeloid Leukemia Biomarker Detection Mergers & Acquisitions Activity
Table 29. United States VS China Acute Myeloid Leukemia Biomarker Detection Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Acute Myeloid Leukemia Biomarker Detection Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Acute Myeloid Leukemia Biomarker Detection Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Acute Myeloid Leukemia Biomarker Detection Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production Market Share (2018-2023)
Table 37. China Based Acute Myeloid Leukemia Biomarker Detection Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production Market Share (2018-2023)
Table 42. Rest of World Based Acute Myeloid Leukemia Biomarker Detection Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production Market Share (2018-2023)
Table 47. World Acute Myeloid Leukemia Biomarker Detection Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Acute Myeloid Leukemia Biomarker Detection Production by Type (2018-2023) & (K Units)
Table 49. World Acute Myeloid Leukemia Biomarker Detection Production by Type (2024-2029) & (K Units)
Table 50. World Acute Myeloid Leukemia Biomarker Detection Production Value by Type (2018-2023) & (USD Million)
Table 51. World Acute Myeloid Leukemia Biomarker Detection Production Value by Type (2024-2029) & (USD Million)
Table 52. World Acute Myeloid Leukemia Biomarker Detection Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Acute Myeloid Leukemia Biomarker Detection Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Acute Myeloid Leukemia Biomarker Detection Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Acute Myeloid Leukemia Biomarker Detection Production by Application (2018-2023) & (K Units)
Table 56. World Acute Myeloid Leukemia Biomarker Detection Production by Application (2024-2029) & (K Units)
Table 57. World Acute Myeloid Leukemia Biomarker Detection Production Value by Application (2018-2023) & (USD Million)
Table 58. World Acute Myeloid Leukemia Biomarker Detection Production Value by Application (2024-2029) & (USD Million)
Table 59. World Acute Myeloid Leukemia Biomarker Detection Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Acute Myeloid Leukemia Biomarker Detection Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 62. Abbott Laboratories Major Business
Table 63. Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Product and Services
Table 64. Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Abbott Laboratories Recent Developments/Updates
Table 66. Abbott Laboratories Competitive Strengths & Weaknesses
Table 67. Bio-Rad Laboratories, Inc. Basic Information, Manufacturing Base and Competitors
Table 68. Bio-Rad Laboratories, Inc. Major Business
Table 69. Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Product and Services
Table 70. Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Bio-Rad Laboratories, Inc. Recent Developments/Updates
Table 72. Bio-Rad Laboratories, Inc. Competitive Strengths & Weaknesses
Table 73. Genmark Saghlk Orinleri Basic Information, Manufacturing Base and Competitors
Table 74. Genmark Saghlk Orinleri Major Business
Table 75. Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Product and Services
Table 76. Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Genmark Saghlk Orinleri Recent Developments/Updates
Table 78. Genmark Saghlk Orinleri Competitive Strengths & Weaknesses
Table 79. Laboratory Corporation of America Holdings Basic Information, Manufacturing Base and Competitors
Table 80. Laboratory Corporation of America Holdings Major Business
Table 81. Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Product and Services
Table 82. Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Laboratory Corporation of America Holdings Recent Developments/Updates
Table 84. Laboratory Corporation of America Holdings Competitive Strengths & Weaknesses
Table 85. Danaher Basic Information, Manufacturing Base and Competitors
Table 86. Danaher Major Business
Table 87. Danaher Acute Myeloid Leukemia Biomarker Detection Product and Services
Table 88. Danaher Acute Myeloid Leukemia Biomarker Detection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Danaher Recent Developments/Updates
Table 90. Danaher Competitive Strengths & Weaknesses
Table 91. Medaysis Company Basic Information, Manufacturing Base and Competitors
Table 92. Medaysis Company Major Business
Table 93. Medaysis Company Acute Myeloid Leukemia Biomarker Detection Product and Services
Table 94. Medaysis Company Acute Myeloid Leukemia Biomarker Detection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Medaysis Company Recent Developments/Updates
Table 96. Medaysis Company Competitive Strengths & Weaknesses
Table 97. NeoGenomics Laboratories Basic Information, Manufacturing Base and Competitors
Table 98. NeoGenomics Laboratories Major Business
Table 99. NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Product and Services
Table 100. NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. NeoGenomics Laboratories Recent Developments/Updates
Table 102. NeoGenomics Laboratories Competitive Strengths & Weaknesses
Table 103. QIAGEN N.V. Basic Information, Manufacturing Base and Competitors
Table 104. QIAGEN N.V. Major Business
Table 105. QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Product and Services
Table 106. QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. QIAGEN N.V. Recent Developments/Updates
Table 108. QIAGEN N.V. Competitive Strengths & Weaknesses
Table 109. Thermo Fisher Scientific, Inc. Basic Information, Manufacturing Base and Competitors
Table 110. Thermo Fisher Scientific, Inc. Major Business
Table 111. Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Product and Services
Table 112. Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Thermo Fisher Scientific, Inc. Recent Developments/Updates
Table 114. GeneTex Basic Information, Manufacturing Base and Competitors
Table 115. GeneTex Major Business
Table 116. GeneTex Acute Myeloid Leukemia Biomarker Detection Product and Services
Table 117. GeneTex Acute Myeloid Leukemia Biomarker Detection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of Acute Myeloid Leukemia Biomarker Detection Upstream (Raw Materials)
Table 119. Acute Myeloid Leukemia Biomarker Detection Typical Customers
Table 120. Acute Myeloid Leukemia Biomarker Detection Typical Distributors
Table 1. World Acute Myeloid Leukemia Biomarker Detection Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Acute Myeloid Leukemia Biomarker Detection Production Value by Region (2018-2023) & (USD Million)
Table 3. World Acute Myeloid Leukemia Biomarker Detection Production Value by Region (2024-2029) & (USD Million)
Table 4. World Acute Myeloid Leukemia Biomarker Detection Production Value Market Share by Region (2018-2023)
Table 5. World Acute Myeloid Leukemia Biomarker Detection Production Value Market Share by Region (2024-2029)
Table 6. World Acute Myeloid Leukemia Biomarker Detection Production by Region (2018-2023) & (K Units)
Table 7. World Acute Myeloid Leukemia Biomarker Detection Production by Region (2024-2029) & (K Units)
Table 8. World Acute Myeloid Leukemia Biomarker Detection Production Market Share by Region (2018-2023)
Table 9. World Acute Myeloid Leukemia Biomarker Detection Production Market Share by Region (2024-2029)
Table 10. World Acute Myeloid Leukemia Biomarker Detection Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Acute Myeloid Leukemia Biomarker Detection Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Acute Myeloid Leukemia Biomarker Detection Major Market Trends
Table 13. World Acute Myeloid Leukemia Biomarker Detection Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Acute Myeloid Leukemia Biomarker Detection Consumption by Region (2018-2023) & (K Units)
Table 15. World Acute Myeloid Leukemia Biomarker Detection Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Acute Myeloid Leukemia Biomarker Detection Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Acute Myeloid Leukemia Biomarker Detection Producers in 2022
Table 18. World Acute Myeloid Leukemia Biomarker Detection Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Acute Myeloid Leukemia Biomarker Detection Producers in 2022
Table 20. World Acute Myeloid Leukemia Biomarker Detection Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Acute Myeloid Leukemia Biomarker Detection Company Evaluation Quadrant
Table 22. World Acute Myeloid Leukemia Biomarker Detection Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Acute Myeloid Leukemia Biomarker Detection Production Site of Key Manufacturer
Table 24. Acute Myeloid Leukemia Biomarker Detection Market: Company Product Type Footprint
Table 25. Acute Myeloid Leukemia Biomarker Detection Market: Company Product Application Footprint
Table 26. Acute Myeloid Leukemia Biomarker Detection Competitive Factors
Table 27. Acute Myeloid Leukemia Biomarker Detection New Entrant and Capacity Expansion Plans
Table 28. Acute Myeloid Leukemia Biomarker Detection Mergers & Acquisitions Activity
Table 29. United States VS China Acute Myeloid Leukemia Biomarker Detection Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Acute Myeloid Leukemia Biomarker Detection Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Acute Myeloid Leukemia Biomarker Detection Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Acute Myeloid Leukemia Biomarker Detection Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production Market Share (2018-2023)
Table 37. China Based Acute Myeloid Leukemia Biomarker Detection Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production Market Share (2018-2023)
Table 42. Rest of World Based Acute Myeloid Leukemia Biomarker Detection Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production Market Share (2018-2023)
Table 47. World Acute Myeloid Leukemia Biomarker Detection Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Acute Myeloid Leukemia Biomarker Detection Production by Type (2018-2023) & (K Units)
Table 49. World Acute Myeloid Leukemia Biomarker Detection Production by Type (2024-2029) & (K Units)
Table 50. World Acute Myeloid Leukemia Biomarker Detection Production Value by Type (2018-2023) & (USD Million)
Table 51. World Acute Myeloid Leukemia Biomarker Detection Production Value by Type (2024-2029) & (USD Million)
Table 52. World Acute Myeloid Leukemia Biomarker Detection Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Acute Myeloid Leukemia Biomarker Detection Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Acute Myeloid Leukemia Biomarker Detection Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Acute Myeloid Leukemia Biomarker Detection Production by Application (2018-2023) & (K Units)
Table 56. World Acute Myeloid Leukemia Biomarker Detection Production by Application (2024-2029) & (K Units)
Table 57. World Acute Myeloid Leukemia Biomarker Detection Production Value by Application (2018-2023) & (USD Million)
Table 58. World Acute Myeloid Leukemia Biomarker Detection Production Value by Application (2024-2029) & (USD Million)
Table 59. World Acute Myeloid Leukemia Biomarker Detection Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Acute Myeloid Leukemia Biomarker Detection Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 62. Abbott Laboratories Major Business
Table 63. Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Product and Services
Table 64. Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Abbott Laboratories Recent Developments/Updates
Table 66. Abbott Laboratories Competitive Strengths & Weaknesses
Table 67. Bio-Rad Laboratories, Inc. Basic Information, Manufacturing Base and Competitors
Table 68. Bio-Rad Laboratories, Inc. Major Business
Table 69. Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Product and Services
Table 70. Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Bio-Rad Laboratories, Inc. Recent Developments/Updates
Table 72. Bio-Rad Laboratories, Inc. Competitive Strengths & Weaknesses
Table 73. Genmark Saghlk Orinleri Basic Information, Manufacturing Base and Competitors
Table 74. Genmark Saghlk Orinleri Major Business
Table 75. Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Product and Services
Table 76. Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Genmark Saghlk Orinleri Recent Developments/Updates
Table 78. Genmark Saghlk Orinleri Competitive Strengths & Weaknesses
Table 79. Laboratory Corporation of America Holdings Basic Information, Manufacturing Base and Competitors
Table 80. Laboratory Corporation of America Holdings Major Business
Table 81. Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Product and Services
Table 82. Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Laboratory Corporation of America Holdings Recent Developments/Updates
Table 84. Laboratory Corporation of America Holdings Competitive Strengths & Weaknesses
Table 85. Danaher Basic Information, Manufacturing Base and Competitors
Table 86. Danaher Major Business
Table 87. Danaher Acute Myeloid Leukemia Biomarker Detection Product and Services
Table 88. Danaher Acute Myeloid Leukemia Biomarker Detection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Danaher Recent Developments/Updates
Table 90. Danaher Competitive Strengths & Weaknesses
Table 91. Medaysis Company Basic Information, Manufacturing Base and Competitors
Table 92. Medaysis Company Major Business
Table 93. Medaysis Company Acute Myeloid Leukemia Biomarker Detection Product and Services
Table 94. Medaysis Company Acute Myeloid Leukemia Biomarker Detection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Medaysis Company Recent Developments/Updates
Table 96. Medaysis Company Competitive Strengths & Weaknesses
Table 97. NeoGenomics Laboratories Basic Information, Manufacturing Base and Competitors
Table 98. NeoGenomics Laboratories Major Business
Table 99. NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Product and Services
Table 100. NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. NeoGenomics Laboratories Recent Developments/Updates
Table 102. NeoGenomics Laboratories Competitive Strengths & Weaknesses
Table 103. QIAGEN N.V. Basic Information, Manufacturing Base and Competitors
Table 104. QIAGEN N.V. Major Business
Table 105. QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Product and Services
Table 106. QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. QIAGEN N.V. Recent Developments/Updates
Table 108. QIAGEN N.V. Competitive Strengths & Weaknesses
Table 109. Thermo Fisher Scientific, Inc. Basic Information, Manufacturing Base and Competitors
Table 110. Thermo Fisher Scientific, Inc. Major Business
Table 111. Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Product and Services
Table 112. Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Thermo Fisher Scientific, Inc. Recent Developments/Updates
Table 114. GeneTex Basic Information, Manufacturing Base and Competitors
Table 115. GeneTex Major Business
Table 116. GeneTex Acute Myeloid Leukemia Biomarker Detection Product and Services
Table 117. GeneTex Acute Myeloid Leukemia Biomarker Detection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of Acute Myeloid Leukemia Biomarker Detection Upstream (Raw Materials)
Table 119. Acute Myeloid Leukemia Biomarker Detection Typical Customers
Table 120. Acute Myeloid Leukemia Biomarker Detection Typical Distributors
LIST OF FIGURES
Figure 1. Acute Myeloid Leukemia Biomarker Detection Picture
Figure 2. World Acute Myeloid Leukemia Biomarker Detection Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Acute Myeloid Leukemia Biomarker Detection Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Acute Myeloid Leukemia Biomarker Detection Production (2018-2029) & (K Units)
Figure 5. World Acute Myeloid Leukemia Biomarker Detection Average Price (2018-2029) & (US$/Unit)
Figure 6. World Acute Myeloid Leukemia Biomarker Detection Production Value Market Share by Region (2018-2029)
Figure 7. World Acute Myeloid Leukemia Biomarker Detection Production Market Share by Region (2018-2029)
Figure 8. North America Acute Myeloid Leukemia Biomarker Detection Production (2018-2029) & (K Units)
Figure 9. Europe Acute Myeloid Leukemia Biomarker Detection Production (2018-2029) & (K Units)
Figure 10. China Acute Myeloid Leukemia Biomarker Detection Production (2018-2029) & (K Units)
Figure 11. Japan Acute Myeloid Leukemia Biomarker Detection Production (2018-2029) & (K Units)
Figure 12. Acute Myeloid Leukemia Biomarker Detection Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Acute Myeloid Leukemia Biomarker Detection Consumption (2018-2029) & (K Units)
Figure 15. World Acute Myeloid Leukemia Biomarker Detection Consumption Market Share by Region (2018-2029)
Figure 16. United States Acute Myeloid Leukemia Biomarker Detection Consumption (2018-2029) & (K Units)
Figure 17. China Acute Myeloid Leukemia Biomarker Detection Consumption (2018-2029) & (K Units)
Figure 18. Europe Acute Myeloid Leukemia Biomarker Detection Consumption (2018-2029) & (K Units)
Figure 19. Japan Acute Myeloid Leukemia Biomarker Detection Consumption (2018-2029) & (K Units)
Figure 20. South Korea Acute Myeloid Leukemia Biomarker Detection Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Acute Myeloid Leukemia Biomarker Detection Consumption (2018-2029) & (K Units)
Figure 22. India Acute Myeloid Leukemia Biomarker Detection Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Acute Myeloid Leukemia Biomarker Detection by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Acute Myeloid Leukemia Biomarker Detection Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Acute Myeloid Leukemia Biomarker Detection Markets in 2022
Figure 26. United States VS China: Acute Myeloid Leukemia Biomarker Detection Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Acute Myeloid Leukemia Biomarker Detection Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Acute Myeloid Leukemia Biomarker Detection Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production Market Share 2022
Figure 30. China Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production Market Share 2022
Figure 32. World Acute Myeloid Leukemia Biomarker Detection Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Acute Myeloid Leukemia Biomarker Detection Production Value Market Share by Type in 2022
Figure 34. Next Generation Sequencing Technology
Figure 35. PCR Detection Technology
Figure 36. World Acute Myeloid Leukemia Biomarker Detection Production Market Share by Type (2018-2029)
Figure 37. World Acute Myeloid Leukemia Biomarker Detection Production Value Market Share by Type (2018-2029)
Figure 38. World Acute Myeloid Leukemia Biomarker Detection Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Acute Myeloid Leukemia Biomarker Detection Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Acute Myeloid Leukemia Biomarker Detection Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Research Institutions
Figure 43. Other
Figure 44. World Acute Myeloid Leukemia Biomarker Detection Production Market Share by Application (2018-2029)
Figure 45. World Acute Myeloid Leukemia Biomarker Detection Production Value Market Share by Application (2018-2029)
Figure 46. World Acute Myeloid Leukemia Biomarker Detection Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Acute Myeloid Leukemia Biomarker Detection Industry Chain
Figure 48. Acute Myeloid Leukemia Biomarker Detection Procurement Model
Figure 49. Acute Myeloid Leukemia Biomarker Detection Sales Model
Figure 50. Acute Myeloid Leukemia Biomarker Detection Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Figure 1. Acute Myeloid Leukemia Biomarker Detection Picture
Figure 2. World Acute Myeloid Leukemia Biomarker Detection Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Acute Myeloid Leukemia Biomarker Detection Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Acute Myeloid Leukemia Biomarker Detection Production (2018-2029) & (K Units)
Figure 5. World Acute Myeloid Leukemia Biomarker Detection Average Price (2018-2029) & (US$/Unit)
Figure 6. World Acute Myeloid Leukemia Biomarker Detection Production Value Market Share by Region (2018-2029)
Figure 7. World Acute Myeloid Leukemia Biomarker Detection Production Market Share by Region (2018-2029)
Figure 8. North America Acute Myeloid Leukemia Biomarker Detection Production (2018-2029) & (K Units)
Figure 9. Europe Acute Myeloid Leukemia Biomarker Detection Production (2018-2029) & (K Units)
Figure 10. China Acute Myeloid Leukemia Biomarker Detection Production (2018-2029) & (K Units)
Figure 11. Japan Acute Myeloid Leukemia Biomarker Detection Production (2018-2029) & (K Units)
Figure 12. Acute Myeloid Leukemia Biomarker Detection Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Acute Myeloid Leukemia Biomarker Detection Consumption (2018-2029) & (K Units)
Figure 15. World Acute Myeloid Leukemia Biomarker Detection Consumption Market Share by Region (2018-2029)
Figure 16. United States Acute Myeloid Leukemia Biomarker Detection Consumption (2018-2029) & (K Units)
Figure 17. China Acute Myeloid Leukemia Biomarker Detection Consumption (2018-2029) & (K Units)
Figure 18. Europe Acute Myeloid Leukemia Biomarker Detection Consumption (2018-2029) & (K Units)
Figure 19. Japan Acute Myeloid Leukemia Biomarker Detection Consumption (2018-2029) & (K Units)
Figure 20. South Korea Acute Myeloid Leukemia Biomarker Detection Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Acute Myeloid Leukemia Biomarker Detection Consumption (2018-2029) & (K Units)
Figure 22. India Acute Myeloid Leukemia Biomarker Detection Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Acute Myeloid Leukemia Biomarker Detection by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Acute Myeloid Leukemia Biomarker Detection Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Acute Myeloid Leukemia Biomarker Detection Markets in 2022
Figure 26. United States VS China: Acute Myeloid Leukemia Biomarker Detection Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Acute Myeloid Leukemia Biomarker Detection Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Acute Myeloid Leukemia Biomarker Detection Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production Market Share 2022
Figure 30. China Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Acute Myeloid Leukemia Biomarker Detection Production Market Share 2022
Figure 32. World Acute Myeloid Leukemia Biomarker Detection Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Acute Myeloid Leukemia Biomarker Detection Production Value Market Share by Type in 2022
Figure 34. Next Generation Sequencing Technology
Figure 35. PCR Detection Technology
Figure 36. World Acute Myeloid Leukemia Biomarker Detection Production Market Share by Type (2018-2029)
Figure 37. World Acute Myeloid Leukemia Biomarker Detection Production Value Market Share by Type (2018-2029)
Figure 38. World Acute Myeloid Leukemia Biomarker Detection Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Acute Myeloid Leukemia Biomarker Detection Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Acute Myeloid Leukemia Biomarker Detection Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Research Institutions
Figure 43. Other
Figure 44. World Acute Myeloid Leukemia Biomarker Detection Production Market Share by Application (2018-2029)
Figure 45. World Acute Myeloid Leukemia Biomarker Detection Production Value Market Share by Application (2018-2029)
Figure 46. World Acute Myeloid Leukemia Biomarker Detection Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Acute Myeloid Leukemia Biomarker Detection Industry Chain
Figure 48. Acute Myeloid Leukemia Biomarker Detection Procurement Model
Figure 49. Acute Myeloid Leukemia Biomarker Detection Sales Model
Figure 50. Acute Myeloid Leukemia Biomarker Detection Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
